Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for June 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Study Finds Allergic Rhinitis, Rheumatoid Arthritis Not Linked
TUESDAY, June 30, 2020 (HealthDay News) — There is not a significant association between allergic rhinitis and the risk of rheumatoid arthritis, according to a review published online June 15 in the Journal of Evidence-Based Medicine.
Abstract/Full Text (subscription or payment may be required)
Trump Administration Asks Supreme Court to Overturn Affordable Care Act
FRIDAY, June 26, 2020 (HealthDay News) — The Trump administration has asked the Supreme Court to overturn the Affordable Care Act (ACA).
Inhibition of Sclerostin May Increase Cardiovascular Risk
THURSDAY, June 25, 2020 (HealthDay News) — Inhibition of sclerostin with romosozumab may increase cardiovascular risk, according to research published in the June 24 issue of Science Translational Medicine.
COVID-19 Hospitalization Up With Prednisone in Rheumatic Disease
TUESDAY, June 23, 2020 (HealthDay News) — For patients with rheumatic disease with COVID-19, glucocorticoids are associated with increased odds of hospitalization, according to a study published in the July issue of the Annals of Rheumatic Diseases.
Safety Climate Perceptions Linked to Health Provider Stress
MONDAY, June 22, 2020 (HealthDay News) — Safety climate perceptions are associated with care practitioner-reported stress and job satisfaction, according to a study published in the May-June issue of the Journal of Healthcare Management.
Court Rules Against Drug Price Disclosures in TV Ads
THURSDAY, June 18, 2020 (HealthDay News) — The U.S. government does not have the legal authority to force drug companies to disclose prices in their TV ads, a federal appeals court says.
Risk Factors for Suicide ID’d in Health Care Professionals
THURSDAY, June 11, 2020 (HealthDay News) — Modifiable and nonmodifiable risk factors for suicide have been identified among health care professionals, according to a study published online June 10 in JAMA Surgery.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Skin Psoriasis, Somatic Comorbidity Up Psychiatric Illness
MONDAY, June 8, 2020 (HealthDay News) — Skin psoriasis and somatic comorbidity are associated with onset of psychiatric illness (PI), according to a study published online June 3 in JAMA Dermatology.
Abstract/Full Text (subscription or payment may be required)
Pneumonia Risk Down With Nitrogen-Containing Bisphosphonates
Nearly Half of Adults With Arthritis Have Arthritis-Attributable Activity Limitations 
COPD Tied to Increased Risk for Death in Patients With Arthritis 
Overactive Bladder Positively Associated With Arthritis 
Review Reveals Limited Effects of Exercise on Hip Osteoarthritis 
Bimekizumab Well Tolerated, Efficacious Over Three Years in Axial Spondyloarthritis 
Nonsurgical Procedure Tied to Improved Osteoarthritis-Related Knee Pain 
GLP-1 Receptor Agonist Use Tied to Reduced Risk for Total Knee Arthroplasty in Knee OA 
